LEQVIO
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
0078-1000 -
Package NDC
0078-1000-60 -
Package NDC
0078-1000-98 -
Application number
NDA214012 -
SPL ID
e4109fce-9d82-4800-8eae-fed97097241f -
SPL set ID
6fc0afca-4513-4c35-b594-6544aee29a44 -
UNII
UPC6BTX7PY -
RxCUI
2588263 -
RxCUI
2588269
What the source publishes
- Labeler
- Novartis Pharmaceuticals Corporation
- Active ingredients
- inclisiran
- Form
- INJECTION, SOLUTION
- Routes
- SUBCUTANEOUS
- Administrative status
- present-in-source-snapshot
- Marketing status
- NDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "LEQVIO",
"splId": "e4109fce-9d82-4800-8eae-fed97097241f",
"labels": [
{
"setId": "6fc0afca-4513-4c35-b594-6544aee29a44",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6fc0afca-4513-4c35-b594-6544aee29a44",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6fc0afca-4513-4c35-b594-6544aee29a44"
}
],
"routes": [
"SUBCUTANEOUS"
],
"labeler": "Novartis Pharmaceuticals Corporation",
"finished": true,
"packaging": [
{
"sample": false,
"description": "1 SYRINGE, GLASS in 1 CARTON (0078-1000-60) / 1.5 mL in 1 SYRINGE, GLASS",
"package_ndc": "0078-1000-60",
"identifierStatus": "well-formed",
"marketing_start_date": "20211222"
},
{
"sample": true,
"description": "1 SYRINGE, GLASS in 1 CARTON (0078-1000-98) / 1.5 mL in 1 SYRINGE, GLASS",
"package_ndc": "0078-1000-98",
"identifierStatus": "well-formed",
"marketing_start_date": "20230217"
}
],
"productId": "0078-1000_e4109fce-9d82-4800-8eae-fed97097241f",
"useDomain": "unknown",
"dosageForm": "INJECTION, SOLUTION",
"productNdc": "0078-1000",
"deaSchedule": null,
"genericName": "inclisiran",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "INCLISIRAN SODIUM",
"strength": "284 mg/1.5mL"
}
],
"applicationNumber": "NDA214012",
"marketingCategory": "NDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20211222",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"unii": [
"UPC6BTX7PY"
],
"rxcui": [
"2588263",
"2588269"
],
"spl_set_id": [
"6fc0afca-4513-4c35-b594-6544aee29a44"
],
"manufacturer_name": [
"Novartis Pharmaceuticals Corporation"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:0078-1000_e4109fce-9d82-4800-8eae-fed97097241f"